NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.505
+0.005 (0.14%)
At close: Mar 9, 2026, 4:00 PM EDT
3.430
-0.075 (-2.14%)
After-hours: Mar 9, 2026, 7:52 PM EDT
NovaBridge Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 404 | 69 | 158 | 347 | 3,647 | 3,324 | |
| Market Cap Growth | 413.31% | -56.10% | -54.60% | -90.48% | 9.73% | - | |
| Enterprise Value | 179 | -134 | -238 | -223 | 2,916 | 3,115 | |
| Last Close Price | 3.50 | 0.85 | 1.90 | 4.18 | 47.39 | 47.15 | |
| PE Ratio | - | - | - | - | - | 46.08 | |
| Forward PE | - | - | - | - | - | 85.14 | |
| PS Ratio | - | - | 249.50 | -223.95 | 263.21 | 14.07 | |
| PB Ratio | 1.56 | 0.34 | 0.65 | 0.82 | 5.08 | 3.86 | |
| P/TBV Ratio | 1.56 | 0.34 | 0.65 | 0.91 | 5.42 | 4.06 | |
| P/FCF Ratio | - | - | - | - | - | 50.99 | |
| P/OCF Ratio | - | - | - | - | - | 50.05 | |
| EV/Sales Ratio | - | - | - | - | 210.43 | 13.18 | |
| EV/EBITDA Ratio | - | - | - | - | - | 120.82 | |
| EV/EBIT Ratio | - | - | - | - | - | 130.71 | |
| EV/FCF Ratio | - | - | - | - | - | 47.79 | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.00 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.08 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.03 | |
| Net Debt / Equity Ratio | -0.87 | -0.84 | -1.27 | -1.16 | -0.91 | -0.85 | |
| Net Debt / EBITDA Ratio | 6.49 | 3.31 | 6.35 | 9.27 | 2.02 | -28.38 | |
| Net Debt / FCF Ratio | 13.24 | 1.59 | 2.10 | 5.31 | 4.15 | -11.22 | |
| Asset Turnover | - | - | 0.00 | - | 0.02 | 0.38 | |
| Quick Ratio | 14.24 | 20.65 | 5.39 | 4.60 | 7.48 | 9.12 | |
| Current Ratio | 14.47 | 20.90 | 5.67 | 4.78 | 7.66 | 9.28 | |
| Return on Equity (ROE) | - | -22.40% | -24.75% | -26.08% | -45.78% | 14.06% | |
| Return on Assets (ROA) | - | -11.05% | -6.38% | -4.73% | -21.69% | 2.41% | |
| Return on Invested Capital (ROIC) | -101.41% | - | - | - | -338.80% | 34.43% | |
| Return on Capital Employed (ROCE) | -13.30% | -25.20% | -15.80% | -11.00% | -41.60% | 2.70% | |
| Earnings Yield | -6.51% | -32.12% | -131.74% | -106.82% | -10.06% | 2.17% | |
| FCF Yield | -4.21% | -154.11% | -93.01% | -26.58% | -4.33% | 1.96% | |
| Buyback Yield / Dilution | -6.88% | 2.45% | -0.86% | -8.63% | -11.11% | -2030.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.